Karah Herdman Parschauer - Net Worth and Insider Trading

Over the past 18 months, Karah Herdman Parschauer made 3 insider transaction in Ultragenyx Pharmaceutical Inc () with a net sale of 11,295. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc () include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .

In summary, during the past 3 months, insiders sold 69,133 shares of Ultragenyx Pharmaceutical Inc () in total and bought 0 shares, with a net sale of 69,133 shares. During the past 18 months, 243,293 shares of Ultragenyx Pharmaceutical Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,293 shares.

Ultragenyx Pharmaceutical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Karah Herdman Parschauer made no insider transaction in Arcturus Therapeutics Holdings Inc (). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc () include a net sale of 116,000 shares made by Pad Chivukula , a net sale of 13,936 shares made by Keith C Kummerfeld , and a net purchase of 5,000 shares made by Joseph E Payne .

In summary, during the past 3 months, insiders sold 26,000 shares of Arcturus Therapeutics Holdings Inc () in total and bought 0 shares, with a net sale of 26,000 shares. During the past 18 months, 129,936 shares of Arcturus Therapeutics Holdings Inc () were sold and 7,222 shares were bought by its insiders, resulting in a net sale of 122,714 shares.

Arcturus Therapeutics Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Karah Herdman Parschauer made 1 insider transaction in Evolus Inc () with a net sale of 11,931. Other recent insider transactions involving Evolus Inc () include a net sale of 278,255 shares made by David Moatazedi , a net sale of 6,102,728 shares made by Medytox Inc. , and a net sale of 46,541 shares made by Rui Avelar .

In summary, during the past 3 months, insiders sold 159,356 shares of Evolus Inc () in total and bought 0 shares, with a net sale of 159,356 shares. During the past 18 months, 8,302,337 shares of Evolus Inc () were sold and 174,967 shares were bought by its insiders, resulting in a net sale of 8,127,370 shares.

Evolus Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anebulo Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anebulo Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anebulo Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Karah Herdman Parschauer made no insider transaction in Tenaya Therapeutics Inc (). Other recent insider transactions involving Tenaya Therapeutics Inc () include a net purchase of 13,599,275 shares made by Column Group Iii Gp, Lp , a net purchase of 13,599,275 shares made by David V Goeddel , and a net sale of 25,800 shares made by Timothy Hoey .

In summary, during the past 3 months, insiders sold 32,609 shares of Tenaya Therapeutics Inc () in total and bought 4,444,444 shares, with a net purchase of 4,411,835 shares. During the past 18 months, 59,437 shares of Tenaya Therapeutics Inc () were sold and 29,921,361 shares were bought by its insiders, resulting in a net purchase of 29,861,924 shares.

Tenaya Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.